Intellia Therapeutics, Inc. (NTLA)

NASDAQ: NTLA · Real-Time Price · USD

7.23

+0.37 (5.39%)

At close: Apr 17, 2025, 4:00 PM

7.38

+0.15 (2.07%)

Pre-market: Apr 21, 2025, 7:04 AM EDT

Intellia Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	57.88	36.28	52.12	33.05	57.99	Upgrade
Revenue Growth (YoY)	59.55%	-30.40%	57.69%	-43.01%	34.55%	Upgrade
Cost of Revenue	466.31	435.07	419.98	229.81	150.41	Upgrade
Gross Profit	-408.43	-398.79	-367.86	-196.75	-92.41	Upgrade
Selling, General & Admin	125.83	116.5	90.31	71.1	44.17	Upgrade
Operating Expenses	125.83	116.5	90.31	71.1	44.17	Upgrade
Operating Income	-534.26	-515.29	-458.16	-267.85	-136.58	Upgrade
Interest & Investment Income	47.81	49.83	8.54	1.28	2.35	Upgrade
Earnings From Equity Investments	-	-15.63	-11.08	-1.33	-	Upgrade
EBT Excluding Unusual Items	-486.46	-481.09	-460.7	-267.89	-134.23	Upgrade
Gain (Loss) on Sale of Investments	-32.57	-	-	-	-	Upgrade
Other Unusual Items	-	-0.1	-13.49	-	-	Upgrade
Pretax Income	-519.02	-481.19	-474.19	-267.89	-134.23	Upgrade
Net Income	-519.02	-481.19	-474.19	-267.89	-134.23	Upgrade
Net Income to Common	-519.02	-481.19	-474.19	-267.89	-134.23	Upgrade
Shares Outstanding (Basic)	99	89	77	71	56	Upgrade
Shares Outstanding (Diluted)	99	89	77	71	56	Upgrade
Shares Change (YoY)	11.35%	15.33%	8.57%	26.63%	18.50%	Upgrade
EPS (Basic)	-5.25	-5.42	-6.16	-3.78	-2.40	Upgrade
EPS (Diluted)	-5.25	-5.42	-6.16	-3.78	-2.40	Upgrade
Free Cash Flow	-354.66	-408.07	-346.85	-237.79	-53.5	Upgrade
Free Cash Flow Per Share	-3.59	-4.60	-4.51	-3.35	-0.96	Upgrade
Gross Margin	-	-	-	-	-159.35%	Upgrade
Operating Margin	-923.10%	-1420.51%	-879.04%	-810.37%	-235.51%	Upgrade
Profit Margin	-896.77%	-1326.51%	-909.78%	-810.49%	-231.46%	Upgrade
Free Cash Flow Margin	-612.78%	-1124.94%	-665.46%	-719.41%	-92.25%	Upgrade
EBITDA	-523.98	-506.32	-450.59	-260.96	-130.27	Upgrade
EBITDA Margin	-	-	-	-	-224.63%	Upgrade
D&A For EBITDA	10.29	8.98	7.57	6.89	6.31	Upgrade
EBIT	-534.26	-515.29	-458.16	-267.85	-136.58	Upgrade
EBIT Margin	-	-	-	-	-235.51%	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q